Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024
Addiction · 2026
DOI: 10.1111/add.70215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction, 2026. Verfasst von Emmert Roberts und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Addiction Centre, King's College London, London, UK. Hauptthemen laut MEDLINE: Methamphetamine, Amphetamine-Related Disorders, Central Nervous System Stimulants. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.
Abstract (Originalsprache)
Background and aims People who use methamphetamine have a standardised mortality ratio 6.8 times greater than the general population, with several countries reporting concerning increases in methamphetamine‐related mortality over the past decade. Methamphetamine use in the United Kingdom (UK) has been reported as largely confined to communities of men who have sex with men (MSM) with no previous large‐scale studies describing mortality associated with methamphetamine. We aimed to determine trends and case characteristics of methamphetamine‐related deaths in the UK.
Design
Retrospective cohort study.
Setting
Coronial records submitted to the National Programme on Substance Use Mortality (NPSUM) in the UK, 1997–2024. Cases Decedents for whom methamphetamine was determined as implicated in death following coronial investigation.
Measurements
Information was available on decedent sociodemographics, characteristics of death and drugs implicated in death.
Findings
136 decedents had methamphetamine implicated in death. The number of deaths per year were observed to be higher over time since the first death recorded in 2006 (2005–2010, 8 deaths; 2011–2015, 24 deaths; 2016–2020, 47 deaths; 2021–2024, 57 deaths). Decedents were predominantly male ( n = 124, 91%) of White ethnicity ( n = 68, 50%) with a mean age of 41.5 years (standard deviation 10.4; range 18–71); 77% had a history of substance dependence, 48% of which involved injecting drug use, and 88% had a history of a mental disorder. The median blood methamphetamine concentration detected at post‐mortem was 0.83 mg/l (interquartile range 0.26, 2.5). Multiple drug toxicity was implicated in the majority of cases ( n = 88, 65%), the most common implicated other drugs being cocaine ( n = 27, 20%), gamma‐hydroxybutyrate ( n = 20, 15%), opioids ( n = 20, 15%), benzodiazepines ( n = 18, 13%), mephedrone ( n = 13, 10%) and ketamine ( n = 12, 8%). Accidental poisoning was the most common direct cause of death ( n = 89, 65%), with other causes including intentional poisoning, cardiovascular disease, aspiration pneumonia and ischemic bowel disease.
Conclusions
Over the past two decades there appears to have been an increase in the number of methamphetamine‐related deaths in the UK. These deaths largely involve polysubstance use within an overwhelmingly male population with a high prevalence of substance dependence and mental health disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Addiction Centre, King's College London, London, UK.
- National Drug Alcohol Research Centre (NDARC), University of New South Wales, Australia.
- Faculty of Life Sciences and Medicine, King's College London, London, UK.
ORCID-Profile: Emmert Roberts, Rebecca McKetin, Caroline Copeland
Förderung
- National Institute for Health and Care Research
Zitieren
APA
Roberts, E., McKetin, R., & Copeland, C. (2026). Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024. Addiction. https://doi.org/10.1111/add.70215
Vancouver
Roberts E, McKetin R, Copeland C. Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024. Addiction. 2026. doi:10.1111/add.70215
BibTeX
@article{Roberts2026,
author = {Roberts, Emmert and McKetin, Rebecca and Copeland, Caroline},
title = {Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024},
journal = {Addiction},
year = {2026},
doi = {10.1111/add.70215}
}
EUVIMED